Valeant's jumbo bond to quench thirst for large liquid issues

NEW YORK, Feb 24 (IFR) - High-yield investors clamoring for chunky-sized trades with ratings closer to investment grade will get another stab at picking up paper when pharma giant Valeant launches a US$9.6bn bond to finance its acquisition of Salix Pharmaceuticals.